Literature DB >> 17876959

An overview on immune system and migraine.

P P Bruno1, F Carpino, G Carpino, A Zicari.   

Abstract

The pathogenesis of migraine is still unclear, but much evidence led us hypothesize that it can be associated with immune system modification, so that a role for cytokines has been suggested. Cytokines are important mediators of the immune and inflammatory pathways and their receptors are widely express in central nervous system (CNS) by all cell types, including neurons, indicating that they can act on neuronal receptors. Cytokines are now considered to be the pain mediators in neurovascular inflammation. Furthermore cytokines may be a cause of the migraine pain: in fact an high levels of chemokines could stimulate the activation of trigeminal nerves, the release of vasoactive peptides or other biochemical mediators, such as nitric oxide, and then to cause inflammation. In this scenario, many studies on humans have focused the attention on peripheral and central levels of cytokines, but data obtained are highly controversial. Since at the moment there is not a conclusive evidence of the role played by cytokines in migraine, the authors present and comment the latest reports regarding cytokine modification and the role of the immune system in migraine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876959

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  33 in total

1.  Differential Expression of Cytokine-Coding Genes among Migraine Patients with and without Aura and Normal Subjects.

Authors:  Mohammad Taheri; Fwad Nicknafs; Omid Hesami; Abdolreza Javadi; Shahram Arsang-Jang; Arezou Sayad; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-11-12       Impact factor: 3.444

2.  Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine.

Authors:  Fengzhi Wang; Qiu He; Zhanxiu Ren; Fuyong Li; Wei Chen; Xiang Lin; Hemin Zhang; Guofeng Tai
Journal:  Neurol Sci       Date:  2014-11-23       Impact factor: 3.307

3.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

4.  Lymphocyte subsets in pediatric migraine.

Authors:  Aron Cseh; Kristof Mark Farkas; Laszlo Derzbach; Katalin Muller; Barna Vasarhelyi; Balazs Szalay; Andras Treszl; Viktor Farkas
Journal:  Neurol Sci       Date:  2012-10-16       Impact factor: 3.307

Review 5.  Dietary considerations in migraine management: does a consistent diet improve migraine?

Authors:  Alan G Finkel; Juanita A Yerry; J Douglas Mann
Journal:  Curr Pain Headache Rep       Date:  2013-11

6.  The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.

Authors:  Fahimeh Martami; Soodeh Razeghi Jahromi; Mansoureh Togha; Zeinab Ghorbani; Maryam Seifishahpar; Atoosa Saidpour
Journal:  Neurol Sci       Date:  2018-07-15       Impact factor: 3.307

7.  Is serum S100B protein an useful biomarker in migraine?

Authors:  Asuman Celikbilek; Seda Sabah; Nermin Tanik; Hakan Ak; Tugay Atalay; Neziha Yilmaz
Journal:  Neurol Sci       Date:  2014-02-16       Impact factor: 3.307

8.  Expression of PIAS Genes in Migraine Patients.

Authors:  Soudeh Ghafouri-Fard; Omid Hesami; Naghme Nazer; Arezou Sayad; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2021-03-24       Impact factor: 3.444

Review 9.  Migraine and neuroinflammation: the inflammasome perspective.

Authors:  Oguzhan Kursun; Muge Yemisci; Arn M J M van den Maagdenberg; Hulya Karatas
Journal:  J Headache Pain       Date:  2021-06-10       Impact factor: 7.277

10.  Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism.

Authors:  Andrew T Martin; Susan M Pinney; Changchun Xie; Robert L Herrick; Yun Bai; Jeanette Buckholz; Vincent T Martin
Journal:  Headache       Date:  2016-09-27       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.